DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway

被引:7
作者
Yang, Bo [1 ]
Huang, Shiqing [1 ]
Chen, Hongming [2 ]
Li, Rizhu [2 ]
Hou, Shihao [1 ]
Zhao, Jingjing [1 ]
Li, Yepeng [1 ]
机构
[1] Youjiang Med Univ Nationalities, Dept Oncol, Affiliated Hosp, 18 Zhongshan Second Rd, Baise 533000, Guangxi Zhuang, Peoples R China
[2] Youjiang Med Univ Nationalities, Dept Cardiothorac Surg, Affiliated Hosp, 18 Zhongshan Second Rd, Baise 533000, Guangxi Zhuang, Peoples R China
关键词
microRNA; A549; cells; proliferation; DNA methyltransferase 3B; neural cell adhesion molecule 1; LUNG-CANCER; DNA METHYLATION; METHYLTRANSFERASES; EXPRESSION; NCAM;
D O I
10.3892/ol.2021.13129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the present study was to examine the epigenetic mechanism by which microRNA (miR)-152-3p regulates proliferation in non-small cell lung cancer A549 cells via neural cell adhesion molecule 1 (NCAM1). Bisulfite sequencing PCR (BSP), the gold standard for methylation detection, uses bisulfite-treated DNA to determine its pattern of methylation. Treatment of DNA with bisulfite converts cytosine residues to uracil, but leaves 5-methylcytosine residues unaffected. It was conducted and demonstrated a relatively high level of methylation in the miR-152-3p promoter region. Chromatin immunoprecipitation was combined with PCR to detect the binding of DNA methyltransferase 3B (DNMT3B) protein to miR-152-3p, which tends to occur in the core region of the miR-152-3p gene in A549 cells. Luciferase assay identified NCAM1 as the target gene of miR-152-3p. MTT, colony formation and Transwell assays indicated that miR-152-3p could decrease cell proliferation and invasion and in addition to reducing the expression level of NCAM1. Overexpression of NCAM1 could attenuate the effect of miR-152-3p. DNMT3B knockdown decreased the proliferative ability of A549 cells and increased the expression of miR-152-3p, while decreased that of NCAM1. After treatment with miR-152-3p inhibitor, these effects were attenuated and the NCAM1 expression level was upregulated. The results indicated that miR-152-3p may suppress the proliferation of A549 cells by downregulating NCAM1. In addition, DNMT3B negatively regulated the expression of miR-152-3p via modulation of the methylation level in the miR-152-3p core region, thus mediating the proliferation of lung tumor cells.
引用
收藏
页数:11
相关论文
共 28 条
  • [21] DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
    Robert, MF
    Morin, S
    Beaulieu, N
    Gauthier, F
    Chute, IC
    Barsalou, A
    MacLeod, AR
    [J]. NATURE GENETICS, 2003, 33 (01) : 61 - 65
  • [22] DNA methylation, methyltransferases, and cancer
    Robertson, KD
    [J]. ONCOGENE, 2001, 20 (24) : 3139 - 3155
  • [23] THE NEURAL CELL-ADHESION MOLECULE (NCAM) AS A REGULATOR OF CELL-CELL INTERACTIONS
    RUTISHAUSER, U
    ACHESON, A
    HALL, AK
    MANN, DM
    SUNSHINE, J
    [J]. SCIENCE, 1988, 240 (4848) : 53 - 57
  • [24] RETRACTED: Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4 (Retracted Article)
    Song, Tieniu
    Zhou, Hui
    Wei, Xiaoping
    Meng, Yuqi
    Guo, Quanwei
    [J]. CANCER GENE THERAPY, 2021, 28 (05) : 455 - 470
  • [25] MicroRNA-152 targets ADAM17 to suppress NSCLC progression
    Su, Yunshu
    Wang, Yuchang
    Zhou, Hongmin
    Lei, Lei
    Xu, Lijun
    [J]. FEBS LETTERS, 2014, 588 (10): : 1983 - 1988
  • [26] Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B
    Wang, Jian-yao
    Cheng, Hao
    Zhang, Hong-yan
    Ye, Yong-qin
    Feng, Qi
    Chen, Zi-min
    Zheng, Yue-lan
    Wu, Zhou-guang
    Wang, Bin
    Yao, Jun
    [J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (1)
  • [27] Win KT, 2014, INT J CLIN EXP PATHO, V7, P451
  • [28] MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
    Xiang, Y.
    Ma, N.
    Wang, D.
    Zhang, Y.
    Zhou, J.
    Wu, G.
    Zhao, R.
    Huang, H.
    Wang, X.
    Qiao, Y.
    Li, F.
    Han, D.
    Wang, L.
    Zhang, G.
    Gao, X.
    [J]. ONCOGENE, 2014, 33 (03) : 378 - 386